148
Views
10
CrossRef citations to date
0
Altmetric
ORIGINAL ARTICLECausation and Prevention

National Cancer Institute Cancer Center Designation and 30-Day Mortality for Hospitalized, Immunocompromised Cancer Patients

, &
Pages 751-757 | Published online: 26 May 2010

REFERENCES

  • Crawford, J.; Dale, D.C.; Kuderer, N.M.; Culakova, E.; Poniewierski, M.S.; Wolff, D.; Lyman, G.H. Risk and timing of neutropenic events in adult cancer patients receiving chemotherapy: the results of a prospective nationwide study of oncology practice. J Natl Compr Canc Netw 2008, 6, 109–118.
  • Larson, E.; Nirenberg, A. Evidence-based nursing practice to prevent infection in hospitalized neutropenic patients with cancer. Oncol Nurs Forum 2004, 31, 717–723.
  • Bodey, G.P. The changing face of febrile neutropenia-from monotherapy to moulds to mucositis. Fever and neutropenia: the early years. J Antimicrob Chemother 2009, 63(Suppl. 1), i3–i13.
  • Caggiano, V.; Weiss, R.V.; Rickert, T.S.; Linde-Zwirble, W.T. Incidence, cost, and mortality of neutropenia hospitalization associated with chemotherapy. Cancer 2005, 103, 1916–1924.
  • Kuderer, N.M.; Dale, D.C.; Crawford, J.; Cosler, L.E.; Lyman, G.H. Mortality, morbidity, and cost associated with febrile neutropenia in adult cancer patients. Cancer 2006, 106, 2258–2266.
  • Friese, C.R.; Wicklin Gillespie, T.; Rice, R.D. Neutropenia: state of the knowledge part II. Oncol Nurs Forum 2006, 33, 1202–1208.
  • Nirenberg, A.; Bush, A.P.; Davis, A.; Friese, C.R.; Gillespie, T.W.; Rice, R.D. Neutropenia: state of the knowledge part I. Oncol Nurs Forum 2006, 33, 1193–1201.
  • Hewitt, M.; Simone, J.V. (eds.) Ensuring Quality Cancer Care. Washington, DC: National Cancer Policy Board, Institute of Medicine, 1999.
  • Friese, C.R.; Lake, E.T.; Aiken, L.H.; Silber, J.H.; Sochalski, J. Hospital nurse practice environments and outcomes for surgical oncology patients. Health Serv Res 2008, 43, 1145–1163.
  • Birkmeyer, J.D.; Dimick, J.B.; Birkmeyer, N.J. Measuring the quality of surgical care: structure, process, or outcomes? J Am Coll Surg 2004, 198, 626–632.
  • Birkmeyer, N.J.O.; Goodney, P.P.; Stukel, T.A.; Hillner, B.E.; Birkmeyer, J.D. Do cancer centers designed by the National Cancer Institute have better surgical outcomes? Cancer 2005, 103, 435–441.
  • Mitchell, P.H.; Shortell, S.M. Adverse outcomes and variations in organization of care delivery. Med Care 1997, 35(Suppl. 11), NS19–NS32.
  • National Cancer Institute. Cancer Centers Program – Cancer Centers List. Bethesda, MD: National Cancer Institute. 2010. Available at http://cancercenters.cancer.gov/cancer_centers/cancer-centers-names.html. Accessed January 26, 2010.
  • Silber, J.H.; Romano, P.S., Rosen, A.K.; Wang, Y.; Even-Shoshan, O.; Volpp, K.G. Failure-to-rescue: comparing definitions to measure quality of care. Med Care 2007, 45, 918–925.
  • Brewster, A.C.; Karlin, B.G.; Hyde, L.A.; Jacobs, C.M.; Bradbury, R.C.; Chae, Y.M. MEDISGRPS: a clinically based approach to classifying hospital patients at admission. Inquiry 1985, 22, 377–387.
  • Iezzoni, L.I.; Moskowitz, M.A. A clinical assessment of MedisGroups. JAMA 1988, 260, 3159–3163.
  • Aiken, L.H.; Clarke, S.P.; Sloane, D.M.; Sochalski, J.; Silber, J.H. Hospital nurse staffing and patient mortality, nurse burnout, and job dissatisfaction. JAMA 2002, 288, 1987–1993.
  • Hartz, A.J.; Krakauer, H.; Kuhn, E.M.; Young, M.; Jacobsen, S.J.; Gay, G.; Muenz, L.; Katzoff, M.; Bailey, R.C.; Rimm, A.A. Hospital characteristics and mortality rates. N Engl J Med 1989, 321, 1720–1725.
  • Silber, J.H.; Rosenbaum, P.R.; Schwartz, J.S.; Ross, R.N.; Williams, S.V. Evaluation of the complication rate as a measure of quality of care in coronary artery bypass graft surgery. JAMA 1995, 274, 317–323.
  • Ayanian, J.Z.; Weissman, J.S. Teaching hospitals and quality of care: a review of the literature. Milbank Q 2002, 80, 569–593.
  • Lake, E.T. Development of the practice environment scale of the nursing work index. Res Nurs Health 2002, 25, 176–188.
  • Lake, E.T., Friese, C.R. Variations in nursing practice environments: relation to staffing and hospital characteristics. Nurs Res 2006, 55, 1–9.
  • Bursac, Z.; Gauss, C.H.; Williams, D.K.; Hosmer, D.W. Purposeful selection of variables in logistic regression. Source Code Biol Med 2008, 3, 17.
  • Hanley, J.A.; McNeil, B.J. The meaning and use of the area under a receiver operating characteristic (ROC) curve. Radiology 1982, 143, 29–36.
  • Rogers, W.H. Regression standard errors in clustered samples. Stata Tech Bull 1993, 13, 19–23.
  • Huber, P.J. The behavior of maximum likelihood estimates under non-standard conditions. Proceedings of the Fifth Berkeley Symposium on Mathematical Statistics and Probability. Vol 1. Berkeley, CA: University of California Press, 1967, 221–233.
  • Jencks, S.F.; Williams, D.K.; Kay, T.L. Assessing hospital-associated deaths from discharge data: the role of length of stay and comorbidities. JAMA 1988, 260, 2240–2246.
  • Nathan, D.; Benz, E.J. Comprehensive cancer centres and the war on cancer. Nat Rev Cancer 2001, 1, 240–245.
  • Klastersky, J.; Paesmans, M.; Rubenstein, E.B.; Boyer, M.; Elting, L.; Feld, R.; Gallagher, J.; Herrstedt, J.; Rapoport, B.; Rolston, K.; Talcott, J. The multinational association for supportive care in cancer risk index: a multinational scoring system for identifying low-risk febrile neutropenic cancer patients. J Clin Oncol 2000, 18, 3038–3051.
  • Escalante, C.P.; Rubenstein, E.B.; Rolston, K.V. Outpatient antibiotic treatment in low-risk febrile neutropenic cancer patients. Support Care Cancer 1996, 4, 358–363.
  • Escalante, C.P.; Rubenstein, E.B.; Rolston, K.V. Outpatient antibiotic therapy for febrile episodes in low-risk neutropenic patients with cancer. Cancer Invest 1997, 15, 237–242.
  • Escalante, C.P.; Weiser, M.A.; Manzullo, E.; Benjamin, R.; Rivera, E.; Lam, T.; Ho, V.; Valdres, R.; Lee, E.L.; Badrina, N.; Fernandez, S.; DeJesus, Y.; Rolston, K. Outcomes of treatment pathways in outpatient treatment of low risk febrile neutropenic cancer patients. Support Care Cancer 2004, 12, 657–662.
  • Rubenstein, E.B.; Rolston, K.; Benjamin, R.S. Outpatient treatment of febrile episodes in low-risk neutropenic patients with cancer. Cancer 1993, 71, 3640–3646.
  • Chamilos, G.; Bamias, A.; Efstathiou, E.; Zorzou, P.M.; Kastritis, E.; Kostis, E.; Papadimitriou, C.; Dimopoulos, M.A. Outpatient treatment of low-risk neutropenic fever in cancer patients using oral moxifloxacin. Cancer 2005, 103, 2629–2635.
  • Malik, I.A.; Khan, W.A.; Karim, M.; Aziz, Z.; Khan, M.A. Feasibility of outpatient management of fever in cancer patients with low-risk neutropenia: results of a prospective randomized trial. Am J Med 1995, 98, 224–231.
  • Sipsas, N.V.; Bodey, G.P.; Kontoyiannis, D.P. Perspectives for the management of febrile neutropenic patients with cancer in the 21st century. Cancer 2005, 103, 1103–1113.
  • Pizzo, P.A. The changing face of febrile neutropenia-from monotherapy to moulds to mucositis. Where do we go from here? J Antimicrob Chemother 2009, 63(Suppl. 1), i16–i17.
  • National Comprehensive Cancer Network. Practice Guidelines in Oncology: Prevention and Treatment of Cancer-Related Infections. Fort Washington, PA: National Comprehensive Cancer Network, 2008 (Retrieved July 15, 2009, from http://www.nccn.org).

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.